Steven Bacchus Zeliadt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Steven Bacchus Zeliadt has a total of 205 co-authors. Here are the top co-authors by number of shared publications:
- Leah M. Backhus
Department of Cardiothoracic Surgery, Division of Thoracic Surgery, Stanford Medicine, Stanford, CA, United States; VA Palo Alto Healthcare System, Palo Alto, CA, United States
6 shared publications Scott Coggeshall
VA Center of Innovation (COIN) for Veteran-Centered and Value-Driven Care, VA Puget Sound Healthcare System, Seattle, WA, USA
6 shared publications- David Edward Reed
University of Washington
4 shared publications David H. Au
Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington
4 shared publications- Ethan Wan Rosser
VA Center of Innovation (COIN) for Veteran-Centered and Value-Driven Care, VA Puget Sound Healthcare System, Seattle, WA, USA
4 shared publications Barbara G Bokhour
Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford, MA, USA
3 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e96346
Extraction of Pain Severity and Functional Interference From Clinical Narratives Using Domain-Informed Large Language Models: Protocol for a Development and Validation Study
Background: Chronic pain is a leading cause of disability and requires multidimensional assessment of pain intensity and functioning, yet electronic health records rarely capture these measures systematically. By contrast, surveys collecting patient-reported outcomes can assess pain over multiple dimensions but remain resource-intensive and difficult to scale for continuous population-level monitoring. Objective: The objective of this study is to develop and validate a domain-informed natural language processing framework to derive pain severity and functional interference outcomes from unstructured clinical narratives. We aim to demonstrate that natural language processing–derived outcomes can serve as a reliable, scalable surrogate for resource-intensive patient-reported surveys. Methods: This study uses a retrospective cohort of 3725 Veterans with chronic musculoskeletal pain initiating complementary and integrative health therapies across 18 Veterans Health Administration Whole Health Flagship sites (2021‐2023). The dataset encompasses longitudinal patient-reported outcome surveys serving as the benchmark, linked with unstructured clinical narratives from the Veterans Health Administration electronic health record. Guided by established psychometric instruments and subject matter expert (SME) input, we developed a seed lexicon and annotation guidelines to identify language distinguishing 3 pain domains: pain severity, interference with enjoyment of life, and interference with general activities. Preliminary large language model (LLM) prompting was used to identify 600 candidate encounters (200 per domain) from 6747 notes across 260 patients for SME annotation, forming a ground truth validation sample. Two candidate LLMs will be evaluated on this sample; the best-performing LLM will generate a large library of span-level annotations to train a scalable, lightweight language model. The study uses a 3-stage validation process: (1) documentation completeness of pain interference in clinical narratives against SME-annotated references; (2) inference accuracy of the LLM-as-annotator and the fine-tuned lightweight model against SME annotations across note-level classification and span-level localization; and (3) concordance between the lightweight model’s output and patient-reported pain, enjoyment, and general activity scores across a range of temporal windows. Results: As of July 2026, the cohort of 3725 Veterans has been identified and linked to clinical notes. The seed lexicon and annotation guidelines have been developed. Applying a developmental LLM to screen 6747 text notes in 6642 unique encounters over a 7-month period for 260 patients, at least 1 of the 3 pain domains was identified in 75% of notes and 99% of patients. SME validation at the encounter level is in progress. Final results from the subsequent knowledge distillation and validation stages are expected in the first half of 2027. Conclusions: This protocol outlines a framework for identifying severe pain intensity and interference from clinical narratives, addressing a critical gap in health care system surveillance. To our knowledge, this is the first study to validate clinical text-based pain outcome extraction against patient-reported outcomes in a nationwide longitudinal cohort. If successful, this approach will enable health care systems to continuously monitor reports of pain-related functional interference and support more holistic, patient-centered pain management at scale.
- 7 October 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e96346
Open AccessExtraction of Pain Severity and Functional Interference From Clinical Narratives Using Domain-Informed Large Language Models: Protocol for a Development and Validation Study
Background: Chronic pain is a leading cause of disability and requires multidimensional assessment of pain intensity and functioning, yet electronic health records rarely capture these measures systematically. By contrast, surveys collecting patient-reported outcomes can assess pain over multiple dimensions but remain resource-intensive and difficult to scale for continuous population-level monitoring. Objective: The objective of this study is to develop and validate a domain-informed natural language processing framework to derive pain severity and functional interference outcomes from unstructured clinical narratives. We aim to demonstrate that natural language processing–derived outcomes can serve as a reliable, scalable surrogate for resource-intensive patient-reported surveys. Methods: This study uses a retrospective cohort of 3725 Veterans with chronic musculoskeletal pain initiating complementary and integrative health therapies across 18 Veterans Health Administration Whole Health Flagship sites (2021‐2023). The dataset encompasses longitudinal patient-reported outcome surveys serving as the benchmark, linked with unstructured clinical narratives from the Veterans Health Administration electronic health record. Guided by established psychometric instruments and subject matter expert (SME) input, we developed a seed lexicon and annotation guidelines to identify language distinguishing 3 pain domains: pain severity, interference with enjoyment of life, and interference with general activities. Preliminary large language model (LLM) prompting was used to identify 600 candidate encounters (200 per domain) from 6747 notes across 260 patients for SME annotation, forming a ground truth validation sample. Two candidate LLMs will be evaluated on this sample; the best-performing LLM will generate a large library of span-level annotations to train a scalable, lightweight language model. The study uses a 3-stage validation process: (1) documentation completeness of pain interference in clinical narratives against SME-annotated references; (2) inference accuracy of the LLM-as-annotator and the fine-tuned lightweight model against SME annotations across note-level classification and span-level localization; and (3) concordance between the lightweight model’s output and patient-reported pain, enjoyment, and general activity scores across a range of temporal windows. Results: As of July 2026, the cohort of 3725 Veterans has been identified and linked to clinical notes. The seed lexicon and annotation guidelines have been developed. Applying a developmental LLM to screen 6747 text notes in 6642 unique encounters over a 7-month period for 260 patients, at least 1 of the 3 pain domains was identified in 75% of notes and 99% of patients. SME validation at the encounter level is in progress. Final results from the subsequent knowledge distillation and validation stages are expected in the first half of 2027. Conclusions: This protocol outlines a framework for identifying severe pain intensity and interference from clinical narratives, addressing a critical gap in health care system surveillance. To our knowledge, this is the first study to validate clinical text-based pain outcome extraction against patient-reported outcomes in a nationwide longitudinal cohort. If successful, this approach will enable health care systems to continuously monitor reports of pain-related functional interference and support more holistic, patient-centered pain management at scale.
- 11 May 2026
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (13) , 3739-3748
Exploring the Ripple Effect: Changes in Quality Measures Before and After Whole Health Adoption in Veterans Health Administration
The Veterans Health Administration (VHA) and other health care systems have been moving to patient-centered health care models with a focus on individual goal setting and patient engagement. In VHA, this model of care is called Whole Health, implementation of which began in 2011. To examine whether Whole Health utilization is associated with subsequent improvements in clinical quality measures of chronic disease management and preventive health care services. Controlled pre/post quality improvement evaluation accounting for secular trends. Veterans at 125 VHA medical centers who utilized care between 10/01/2022 and 03/31/2023. INTERVENTIONS: Veterans with Whole Health utilization that included Whole Health educational classes, coaching activities, and Whole Health clinical care conversations with providers were assessed alongside reference patients who used general VHA care during the same period. MAIN MEASURES: Change in clinical quality measures one month before using Whole Health care to 6 months after. The population included 548,968 Whole Health users and 5,428,413 general VHA users. Improvements were observed in all nine clinical quality measures following Whole Health utilization and continued to improve over 6 months. The proportions of Whole Health cohorts with quality improvements were greater than the reference cohorts over the same period. For example, among patients with diabetes, 80.1% of the Whole Health group had good HbA1c control (<8%) at 6 months compared to 74.9% before using Whole Health, an increase of 5.2% (95% CI 4.8-5.6%). The adjusted proportion improving after accounting for demographic and clinical characteristics as well as secular trends in the reference cohort was 4.4% (95% CI 4.1-4.7%). These exploratory findings observed that Whole Health utilization was associated with subsequent improvements in health care quality, suggesting this patient-centered care model can potentially augment primary care, achieving a ripple effect improving chronic disease management and preventive care adherence through increased patient activation and engagement.
- 11 May 2026
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (13) , 3739-3748
Exploring the Ripple Effect: Changes in Quality Measures Before and After Whole Health Adoption in Veterans Health Administration
The Veterans Health Administration (VHA) and other health care systems have been moving to patient-centered health care models with a focus on individual goal setting and patient engagement. In VHA, this model of care is called Whole Health, implementation of which began in 2011. To examine whether Whole Health utilization is associated with subsequent improvements in clinical quality measures of chronic disease management and preventive health care services. Controlled pre/post quality improvement evaluation accounting for secular trends. Veterans at 125 VHA medical centers who utilized care between 10/01/2022 and 03/31/2023. INTERVENTIONS: Veterans with Whole Health utilization that included Whole Health educational classes, coaching activities, and Whole Health clinical care conversations with providers were assessed alongside reference patients who used general VHA care during the same period. MAIN MEASURES: Change in clinical quality measures one month before using Whole Health care to 6 months after. The population included 548,968 Whole Health users and 5,428,413 general VHA users. Improvements were observed in all nine clinical quality measures following Whole Health utilization and continued to improve over 6 months. The proportions of Whole Health cohorts with quality improvements were greater than the reference cohorts over the same period. For example, among patients with diabetes, 80.1% of the Whole Health group had good HbA1c control (<8%) at 6 months compared to 74.9% before using Whole Health, an increase of 5.2% (95% CI 4.8-5.6%). The adjusted proportion improving after accounting for demographic and clinical characteristics as well as secular trends in the reference cohort was 4.4% (95% CI 4.1-4.7%). These exploratory findings observed that Whole Health utilization was associated with subsequent improvements in health care quality, suggesting this patient-centered care model can potentially augment primary care, achieving a ripple effect improving chronic disease management and preventive care adherence through increased patient activation and engagement.
- 24 April 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- p. OP2501200
Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for Lung Cancer Survivors in a Nationwide Health Care System
PURPOSE: With the growing number of cancer survivors and projected shortages of oncology providers, understanding who delivers survivorship care has important implications for care quality. We examined follow-up provider patterns among lung cancer survivors in the Veterans Health Administration (VHA) system and assessed variation in receipt of guideline-concordant computed tomography (CT) imaging. METHODS: We conducted a retrospective cohort study of 20,532 Veterans with stage I to III non–small cell lung cancer who received definitive treatment between 2008 and 2016. The primary exposure was the lung cancer survivor's follow-up provider specialty, defined as the specialty with whom the patient received the most post-treatment follow-up visits. We evaluated associations between treatment type and follow-up provider specialty and compared receipt of guideline-concordant surveillance imaging, defined as chest CT performed 120-270 days after treatment, across specialties using multivariable logistic regression, adjusted for demographic, clinical, and facility characteristics. RESULTS: Follow-up care frequently shifted to specialties different from those delivering definitive treatment. Among patients treated with surgery alone, most patients, 61% transitioned to primary care for follow-up, while 27% remained with surgery. Patients followed by medical oncology had the highest rates of guideline-concordant chest CT (72.8% v 66.2% in primary care, adjusted odds ratio, 1.42 [95% CI, 1.31 to 1.53]; P < .001). Chest radiography was used in 26% of cases, most often in primary care and surgical clinics. CONCLUSION: Survivorship follow-up for lung cancer in the VHA often shifted to primary care, where adherence to guideline-concordant chest CT was lower than in medical oncology. These shifts in care may have further implications for post-treatment outcomes and survivorship care, highlighting the opportunity to support nononcology providers in delivering guideline-concordant care as survivorship workforce demands grow.
- 24 April 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- p. OP2501200
Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for Lung Cancer Survivors in a Nationwide Health Care System
PURPOSE: With the growing number of cancer survivors and projected shortages of oncology providers, understanding who delivers survivorship care has important implications for care quality. We examined follow-up provider patterns among lung cancer survivors in the Veterans Health Administration (VHA) system and assessed variation in receipt of guideline-concordant computed tomography (CT) imaging. METHODS: We conducted a retrospective cohort study of 20,532 Veterans with stage I to III non–small cell lung cancer who received definitive treatment between 2008 and 2016. The primary exposure was the lung cancer survivor's follow-up provider specialty, defined as the specialty with whom the patient received the most post-treatment follow-up visits. We evaluated associations between treatment type and follow-up provider specialty and compared receipt of guideline-concordant surveillance imaging, defined as chest CT performed 120-270 days after treatment, across specialties using multivariable logistic regression, adjusted for demographic, clinical, and facility characteristics. RESULTS: Follow-up care frequently shifted to specialties different from those delivering definitive treatment. Among patients treated with surgery alone, most patients, 61% transitioned to primary care for follow-up, while 27% remained with surgery. Patients followed by medical oncology had the highest rates of guideline-concordant chest CT (72.8% v 66.2% in primary care, adjusted odds ratio, 1.42 [95% CI, 1.31 to 1.53]; P < .001). Chest radiography was used in 26% of cases, most often in primary care and surgical clinics. CONCLUSION: Survivorship follow-up for lung cancer in the VHA often shifted to primary care, where adherence to guideline-concordant chest CT was lower than in medical oncology. These shifts in care may have further implications for post-treatment outcomes and survivorship care, highlighting the opportunity to support nononcology providers in delivering guideline-concordant care as survivorship workforce demands grow.
- Open Access
- 1 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Extracting Pain Severity and Functional Interference from Clinical Narratives Using Domain-Informed Large Language Models: Study Protocol (Preprint)
BACKGROUND Chronic pain is a leading cause of disability and requires multidimensional assessment of pain intensity and functioning, yet electronic health records (EHRs) rarely capture these measures systematically. By contrast, surveys collecting patient-reported outcomes can assess pain over multiple dimensions but remain resource-intensive and difficult to scale for continuous population-level monitoring. OBJECTIVE The objective of this study is to develop and validate a domain-informed natural language processing (NLP) framework to derive pain severity and functional interference outcomes from unstructured clinical narratives. Using a benchmark dataset of 3,726 Veterans with longitudinal survey measures, we aim to demonstrate that NLP-derived outcomes can serve as a reliable, scalable surrogate for resource-intensive patient-reported surveys. METHODS This study utilizes a retrospective cohort of 3,726 Veterans with chronic musculoskeletal pain initiating Complementary and Integrative Health (CIH) therapies across 18 Veterans Health Administration (VA) Whole Health Flagship sites (2021–2023). The dataset encompasses longitudinal patient-reported outcome surveys serving as the benchmark, linked with both structured and unstructured data from the VA EHR. To guide extraction and enable scalable processing, we developed a seed lexicon and annotation guidelines based on established psychometric instruments and input from subject matter experts (SMEs). Currently, SMEs are annotating clinical notes in iterative batches. Upon completion, a large language model (LLM) will annotate additional notes. These annotations will be used to fine-tune a lightweight language model capable of processing the entire cohort. The study employs a three-stage validation process, assessing: (1) documentation completeness; (2) inference accuracy, evaluating agreement between model outputs and SME annotations at both the LLM and fine-tuned model levels; and (3) concordance with patient-reported outcomes captured independently from the EHR. RESULTS To date, a cohort of 3,726 Veterans has been identified. The longitudinal survey data have been linked to clinical notes corresponding to the survey time period. The seed lexicon and annotation guidelines have been developed. Annotation is underway in iterative batches to drive the subsequent LLM adaptation and three-stage validation. CONCLUSIONS This protocol outlines a framework for identifying severe pain interference from clinical narratives, addressing a critical gap in health care system surveillance. To our knowledge, this is the first study to validate clinical text-based pain outcome extraction against patient-reported outcomes in a nationwide longitudinal cohort. If successful, this approach will enable health care systems to continuously monitor pain-related functional interference and support more holistic, patient-centered pain management at scale.
- 1 April 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessExtracting Pain Severity and Functional Interference from Clinical Narratives Using Domain-Informed Large Language Models: Study Protocol (Preprint)
BACKGROUND Chronic pain is a leading cause of disability and requires multidimensional assessment of pain intensity and functioning, yet electronic health records (EHRs) rarely capture these measures systematically. By contrast, surveys collecting patient-reported outcomes can assess pain over multiple dimensions but remain resource-intensive and difficult to scale for continuous population-level monitoring. OBJECTIVE The objective of this study is to develop and validate a domain-informed natural language processing (NLP) framework to derive pain severity and functional interference outcomes from unstructured clinical narratives. Using a benchmark dataset of 3,726 Veterans with longitudinal survey measures, we aim to demonstrate that NLP-derived outcomes can serve as a reliable, scalable surrogate for resource-intensive patient-reported surveys. METHODS This study utilizes a retrospective cohort of 3,726 Veterans with chronic musculoskeletal pain initiating Complementary and Integrative Health (CIH) therapies across 18 Veterans Health Administration (VA) Whole Health Flagship sites (2021–2023). The dataset encompasses longitudinal patient-reported outcome surveys serving as the benchmark, linked with both structured and unstructured data from the VA EHR. To guide extraction and enable scalable processing, we developed a seed lexicon and annotation guidelines based on established psychometric instruments and input from subject matter experts (SMEs). Currently, SMEs are annotating clinical notes in iterative batches. Upon completion, a large language model (LLM) will annotate additional notes. These annotations will be used to fine-tune a lightweight language model capable of processing the entire cohort. The study employs a three-stage validation process, assessing: (1) documentation completeness; (2) inference accuracy, evaluating agreement between model outputs and SME annotations at both the LLM and fine-tuned model levels; and (3) concordance with patient-reported outcomes captured independently from the EHR. RESULTS To date, a cohort of 3,726 Veterans has been identified. The longitudinal survey data have been linked to clinical notes corresponding to the survey time period. The seed lexicon and annotation guidelines have been developed. Annotation is underway in iterative batches to drive the subsequent LLM adaptation and three-stage validation. CONCLUSIONS This protocol outlines a framework for identifying severe pain interference from clinical narratives, addressing a critical gap in health care system surveillance. To our knowledge, this is the first study to validate clinical text-based pain outcome extraction against patient-reported outcomes in a nationwide longitudinal cohort. If successful, this approach will enable health care systems to continuously monitor pain-related functional interference and support more holistic, patient-centered pain management at scale.
- 19 December 2025
- Published by Springer Nature in Journal of General Internal Medicine
The Role of Whole Health in Enhancing Tobacco Cessation Outcomes for Veterans: A Retrospective Cohort Study
Veterans Health Administration (VHA) has been implementing Whole Health, a patient-centered model of healthcare which emphasizes supporting and empowering patients to take charge of their health and well-being. However, its impact upon tobacco cessation has not been investigated previously. To conduct a program evaluation of the real-world impact of offering Whole Health services to veterans who are current tobacco users on subsequent tobacco cessation rates and utilization of cessation medications. This retrospective study identified current tobacco users initiating four types of Whole Health services with potential indications for tobacco cessation. Nearest neighbor propensity score matching was used to identify comparison groups of similar patients engaged in VHA care without exposure to these services. VHA patients who utilized at least 1 of the services between 10/1/2016 and 3/1/2023 and were current tobacco users at the time of initial utilization (n = 37,311), and matched comparison patients. Whole Health services included three complementary and integrative health (CIH) therapies - mindfulness meditation, acupuncture, and clinical hypnosis - and Whole Health coaching. Thirteenth-month sustained tobacco cessation documented in the medical record and cessation medication use within 6 and 12 months of cohort entry. Veterans who used meditation (HR = 1.25, 95% CI [1.13, 1.39]), acupuncture (HR = 1.14, 95% CI [1.09, 1.18]), and Whole Health coaching (HR = 1.18, 95% CI [1.08, 1.28]) had higher rates of sustained cessation compared with matched comparison patients. A non-significant association between clinical hypnosis and sustained cessation (HR = 1.12, 95% CI [0.83, 1.50]) was observed. Meditation, clinical hypnosis, and Whole Health coaching were associated with higher cessation medication use, while acupuncture was associated with lower use. This study suggests that Whole Health services offered by VHA including meditation, acupuncture, clinical hypnosis, and Whole Health coaching may be an effective means of empowering veterans to reduce their tobacco utilization.
- 19 December 2025
- Published by Springer Nature in Journal of General Internal Medicine
The Role of Whole Health in Enhancing Tobacco Cessation Outcomes for Veterans: A Retrospective Cohort Study
Veterans Health Administration (VHA) has been implementing Whole Health, a patient-centered model of healthcare which emphasizes supporting and empowering patients to take charge of their health and well-being. However, its impact upon tobacco cessation has not been investigated previously. To conduct a program evaluation of the real-world impact of offering Whole Health services to veterans who are current tobacco users on subsequent tobacco cessation rates and utilization of cessation medications. This retrospective study identified current tobacco users initiating four types of Whole Health services with potential indications for tobacco cessation. Nearest neighbor propensity score matching was used to identify comparison groups of similar patients engaged in VHA care without exposure to these services. VHA patients who utilized at least 1 of the services between 10/1/2016 and 3/1/2023 and were current tobacco users at the time of initial utilization (n = 37,311), and matched comparison patients. Whole Health services included three complementary and integrative health (CIH) therapies - mindfulness meditation, acupuncture, and clinical hypnosis - and Whole Health coaching. Thirteenth-month sustained tobacco cessation documented in the medical record and cessation medication use within 6 and 12 months of cohort entry. Veterans who used meditation (HR = 1.25, 95% CI [1.13, 1.39]), acupuncture (HR = 1.14, 95% CI [1.09, 1.18]), and Whole Health coaching (HR = 1.18, 95% CI [1.08, 1.28]) had higher rates of sustained cessation compared with matched comparison patients. A non-significant association between clinical hypnosis and sustained cessation (HR = 1.12, 95% CI [0.83, 1.50]) was observed. Meditation, clinical hypnosis, and Whole Health coaching were associated with higher cessation medication use, while acupuncture was associated with lower use. This study suggests that Whole Health services offered by VHA including meditation, acupuncture, clinical hypnosis, and Whole Health coaching may be an effective means of empowering veterans to reduce their tobacco utilization.
- Open Access
- 1 October 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11, e76515
Adherence to Posttreatment Surveillance Guidelines in Non–Small Cell Lung Cancer: Retrospective Cohort Study
Background: Several guidelines recommend posttreatment surveillance for non–small cell lung cancer (NSCLC). However, studies evaluating surveillance patterns often cannot distinguish between imaging ordered for surveillance versus for symptoms suggestive of recurrence. Moreover, early recurrences and other competing events hamper efforts to determine true surveillance rates because of wide variability in reported guideline adherence in clinical practice. Leveraging comprehensive Veterans Health Administration data, we developed a novel competing risks framework to describe the patterns and predictors of NSCLC imaging surveillance. Objective: This study aims to examine posttreatment surveillance to estimate the true surveillance rates and predictors of guideline-concordant care in patients with early-stage NSCLC. Methods: The study cohort comprised veterans who were treated for stage 1 to 3 NSCLC between 2008 and 2016 and who survived for ≥6 months. Clinical documents and radiology reports were abstracted for image indication and clinical information. We estimated the cumulative probability of receiving guideline-concordant surveillance, defined as chest computed tomography imaging within 4 to 9 months after treatment, accounting for competing risks and censoring. Multivariable cause-specific Cox regression was used to estimate associations between patient factors and guideline-concordant surveillance, with adjustments made for multiple comparisons. Results: The cohort consisted of 1888 patients. The mean age of the analysis cohort was 66.4 (SD 7.9) years; 95.9% (1811/1888) of the patients were male, 71.1% (1342/1888) of the patients were White, and 43.1% (814/1888) were married. Of the 1888 patients, 57% (n=1076) presented with stage 1 disease, and the most common treatment modality was surgery alone (n=1068, 56.6%). The most common type of imaging performed during the initial 120- to 270-day window was chest computed tomography (1460/3278, 44.5%). Chest X-rays accounted for 36.3% (1190/3278) of all imaging performed, while the remaining 11.8% (386/3278) and 7.4% (242/3278) were positron emission tomography scans or other imaging modalities, respectively. Compared to the years 2008 to 2010, patients treated for NSCLC from 2014 to 2016 had a significantly higher likelihood of receiving guideline-concordant surveillance (hazard ratio 1.42, P <.001). Conclusions: In this unique application of a competing risks framework, the rate of guideline-concordant surveillance in this national cohort was lower than that reported in many previous studies. This finding highlights a potentially substantial gap in surveillance among eligible, asymptomatic lung cancer survivors. More strategies are needed to measure the true rate of guideline-concordant surveillance, along with education and advocacy to ensure guideline-concordant care.
- 1 October 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11, e76515
Open AccessAdherence to Posttreatment Surveillance Guidelines in Non–Small Cell Lung Cancer: Retrospective Cohort Study
Background: Several guidelines recommend posttreatment surveillance for non–small cell lung cancer (NSCLC). However, studies evaluating surveillance patterns often cannot distinguish between imaging ordered for surveillance versus for symptoms suggestive of recurrence. Moreover, early recurrences and other competing events hamper efforts to determine true surveillance rates because of wide variability in reported guideline adherence in clinical practice. Leveraging comprehensive Veterans Health Administration data, we developed a novel competing risks framework to describe the patterns and predictors of NSCLC imaging surveillance. Objective: This study aims to examine posttreatment surveillance to estimate the true surveillance rates and predictors of guideline-concordant care in patients with early-stage NSCLC. Methods: The study cohort comprised veterans who were treated for stage 1 to 3 NSCLC between 2008 and 2016 and who survived for ≥6 months. Clinical documents and radiology reports were abstracted for image indication and clinical information. We estimated the cumulative probability of receiving guideline-concordant surveillance, defined as chest computed tomography imaging within 4 to 9 months after treatment, accounting for competing risks and censoring. Multivariable cause-specific Cox regression was used to estimate associations between patient factors and guideline-concordant surveillance, with adjustments made for multiple comparisons. Results: The cohort consisted of 1888 patients. The mean age of the analysis cohort was 66.4 (SD 7.9) years; 95.9% (1811/1888) of the patients were male, 71.1% (1342/1888) of the patients were White, and 43.1% (814/1888) were married. Of the 1888 patients, 57% (n=1076) presented with stage 1 disease, and the most common treatment modality was surgery alone (n=1068, 56.6%). The most common type of imaging performed during the initial 120- to 270-day window was chest computed tomography (1460/3278, 44.5%). Chest X-rays accounted for 36.3% (1190/3278) of all imaging performed, while the remaining 11.8% (386/3278) and 7.4% (242/3278) were positron emission tomography scans or other imaging modalities, respectively. Compared to the years 2008 to 2010, patients treated for NSCLC from 2014 to 2016 had a significantly higher likelihood of receiving guideline-concordant surveillance (hazard ratio 1.42, P <.001). Conclusions: In this unique application of a competing risks framework, the rate of guideline-concordant surveillance in this national cohort was lower than that reported in many previous studies. This finding highlights a potentially substantial gap in surveillance among eligible, asymptomatic lung cancer survivors. More strategies are needed to measure the true rate of guideline-concordant surveillance, along with education and advocacy to ensure guideline-concordant care.
The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening
Tobacco use is the primary contributor to disease and death in the United States, and cigarette smoking is the leading risk factor for lung cancer. Safe and effective treatments for tobacco dependence exist; however, access to and use of tobacco treatment remains low. The most recent Centers for Medicare and Medicaid Services National Coverage Determination requires a shared decision‐making visit for lung cancer screening that includes counseling on the importance of maintaining cigarette smoking abstinence if a person formerly smoked; or the importance of smoking cessation if a person currently smokes and, if appropriate, furnishing of information about tobacco‐cessation interventions. The directive is not well defined and provides little guidance for delivering high‐quality cessation services. Effective integration of best practices for tobacco treatment in the context of lung cancer screening must extend far beyond recommendations to quit, patient literature to reinforce quitting, and available evidence‐based treatments. To optimize the provision of tobacco treatment and improve health outcomes in people being screened for lung cancer, the American Cancer Society National Lung Cancer Roundtable Tobacco Treatment in the Context of Lung Cancer Screening Task Group recommends: (1) specify quality indicators and document tobacco treatment delivery; (2) embed tobacco treatment in lung cancer screening; (3) advocate for increased access to tobacco treatment; (4) build and train lung cancer screening staff; (5) provide full coverage of treatment medications; (6) leverage electronic health records to improve the provision of cessation services to lung cancer screenees; and (7) identify and address contextual barriers to incorporating tobacco treatment guidelines in screening.
The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening
Tobacco use is the primary contributor to disease and death in the United States, and cigarette smoking is the leading risk factor for lung cancer. Safe and effective treatments for tobacco dependence exist; however, access to and use of tobacco treatment remains low. The most recent Centers for Medicare and Medicaid Services National Coverage Determination requires a shared decision‐making visit for lung cancer screening that includes counseling on the importance of maintaining cigarette smoking abstinence if a person formerly smoked; or the importance of smoking cessation if a person currently smokes and, if appropriate, furnishing of information about tobacco‐cessation interventions. The directive is not well defined and provides little guidance for delivering high‐quality cessation services. Effective integration of best practices for tobacco treatment in the context of lung cancer screening must extend far beyond recommendations to quit, patient literature to reinforce quitting, and available evidence‐based treatments. To optimize the provision of tobacco treatment and improve health outcomes in people being screened for lung cancer, the American Cancer Society National Lung Cancer Roundtable Tobacco Treatment in the Context of Lung Cancer Screening Task Group recommends: (1) specify quality indicators and document tobacco treatment delivery; (2) embed tobacco treatment in lung cancer screening; (3) advocate for increased access to tobacco treatment; (4) build and train lung cancer screening staff; (5) provide full coverage of treatment medications; (6) leverage electronic health records to improve the provision of cessation services to lung cancer screenees; and (7) identify and address contextual barriers to incorporating tobacco treatment guidelines in screening.
- 11 August 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (11) , 2308-2316
Prostate Cancer Imaging Stewardship: a multimodal, physician-centered intervention for guideline-concordant imaging
Background: Inappropriate imaging to stage low-risk prostate cancer is considered low-value care. Determining the effectiveness of a theory-based intervention—Prostate Cancer Imaging Stewardship (PCIS)—to promote guideline-concordant imaging. Methods: A stepped-wedge, cluster-randomized trial, PCIS, was conducted between March 2018 and March 2021 at 10 Veterans Health Administration medical centers (VAMCs) initially selected for prostate cancer volume, geographic diversity, and willingness to participate. Intervention initiations at sites were randomized in 3-month intervals. We enrolled 61 urology providers who treat prostate cancer at participating sites. Outcomes were assessed among 2302 patients with incident prostate cancer aged 18-85 years. PCIS combines 3 evidence-based provider-focused behavior change strategies: (1) Clinical Reminder Order Check triggered when a provider attempted to order imaging for a patient with prostate-specific antigen < 20 ng/mL, (2) VAMC-level academic detailing at initiation and every 3 months thereafter, and (3) Audit and Feedback for providers to improve their imaging performance. The main outcome was guideline-discordant nuclear medicine bone scan (NMBS) imaging for low-risk prostate cancer patients. Results: NMBS imaging would be consistent with National Comprehensive Cancer Network guidelines in 878 patients (38%) and inconsistent in 1424 patients (62%). Among patients not requiring NMBS, 141/690 (20.4%) received guideline-discordant imaging (ie, NMBS ordered) during Control compared with 109/734 (14.9%) during Intervention (odds ratio [OR] = 0.54, P = .04). Among patients requiring a NMBS, 29 of 425 (6.8%) did not receive one (ie, guideline-discordant imaging) during Control compared with 25 of 453 (5.5%) during the Intervention (OR = 1.36, P = .36). Conclusion: PCIS significantly reduced low-value, guideline-discordant NMBS imaging among low-risk prostate cancer patients without negatively affecting necessary imaging for high-risk patients. Clinical Trials Registration: NCT03445559.
- 11 August 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (11) , 2308-2316
Prostate Cancer Imaging Stewardship: a multimodal, physician-centered intervention for guideline-concordant imaging
Background: Inappropriate imaging to stage low-risk prostate cancer is considered low-value care. Determining the effectiveness of a theory-based intervention—Prostate Cancer Imaging Stewardship (PCIS)—to promote guideline-concordant imaging. Methods: A stepped-wedge, cluster-randomized trial, PCIS, was conducted between March 2018 and March 2021 at 10 Veterans Health Administration medical centers (VAMCs) initially selected for prostate cancer volume, geographic diversity, and willingness to participate. Intervention initiations at sites were randomized in 3-month intervals. We enrolled 61 urology providers who treat prostate cancer at participating sites. Outcomes were assessed among 2302 patients with incident prostate cancer aged 18-85 years. PCIS combines 3 evidence-based provider-focused behavior change strategies: (1) Clinical Reminder Order Check triggered when a provider attempted to order imaging for a patient with prostate-specific antigen < 20 ng/mL, (2) VAMC-level academic detailing at initiation and every 3 months thereafter, and (3) Audit and Feedback for providers to improve their imaging performance. The main outcome was guideline-discordant nuclear medicine bone scan (NMBS) imaging for low-risk prostate cancer patients. Results: NMBS imaging would be consistent with National Comprehensive Cancer Network guidelines in 878 patients (38%) and inconsistent in 1424 patients (62%). Among patients not requiring NMBS, 141/690 (20.4%) received guideline-discordant imaging (ie, NMBS ordered) during Control compared with 109/734 (14.9%) during Intervention (odds ratio [OR] = 0.54, P = .04). Among patients requiring a NMBS, 29 of 425 (6.8%) did not receive one (ie, guideline-discordant imaging) during Control compared with 25 of 453 (5.5%) during the Intervention (OR = 1.36, P = .36). Conclusion: PCIS significantly reduced low-value, guideline-discordant NMBS imaging among low-risk prostate cancer patients without negatively affecting necessary imaging for high-risk patients. Clinical Trials Registration: NCT03445559.
- 1 June 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (6) , 863-871
Incidence and Predictors of Long-Term Hypnotic Receipt among Patients with Chronic Obstructive Pulmonary Disease
Rationale: Many patients with chronic obstructive pulmonary disease (COPD) receive hypnotic prescriptions to mitigate insomnia symptoms. Although clinical practice guidelines advise short-term use, patients often receive these medications on a long-term basis. Because patients with COPD may be more susceptible to adverse effects of hypnotic medication, it is critical that we better understand the incidence and potential influences of this practice. Objectives: To characterize the incidence and predictors of guideline-discordant long-term receipt of hypnotic medications among patients with COPD. Methods: Using nationwide Veterans Health Administration data, we identified patients with clinically diagnosed COPD from 2010 to 2019 without prior hypnotic medication receipt in the previous 1 year. To identify individuals with new hypnotic agent use, we restricted this sample to those who received at least 30 total days of zolpidem, melatonin, trazodone, and/or doxepin within a 90-day period. We defined long-term hypnotic medication receipt as continued availability of one of these hypnotic medications for ≥30 days within the subsequent 90-day period. We then used a mixed-effects logistic regression model to assess patient and site-level associations with long-term receipt. Results: Among 4,262 patients with COPD and new hypnotic medication receipt, 55.6% (n = 2,371) continued to receive hypnotic medications on a long-term basis. Long-term receipt was positively associated with short-acting β-agonist receipt (for every 10% increase in days with short-acting β-agonist availability, odds ratio [OR], 1.03; 95% confidence interval [CI], 1.02–1.05), maintenance inhaler prescriptions (monotherapy, OR, 1.35; 95% CI, 1.10–1.68; dual therapy, OR, 1.43; 95% CI, 1.20–1.70; triple therapy, OR, 1.54; 95% CI, 1.24–1.91), posttraumatic stress disorder (OR, 1.21; 95% CI, 1.02–1.44), major depressive disorder (OR, 1.24; 95% CI, 1.07–1.44), anxiety disorder (OR, 1.21; 95% CI, 1.03–1.44), and more frequent primary care visits (more than five visits in the past 12 mo, OR, 1.86; 95% CI, 1.19–2.90). Long-term receipt was negatively associated with initial receipt of melatonin (OR, 0.70; 95% CI, 0.55–0.91) and more than one pulmonary visit in the previous 12 months (OR, 0.74; 95% CI, 0.56–0.97). Conclusions: Despite guideline recommendations, long-term hypnotic medication receipt is common among patients with COPD. Future work to prevent long-term hypnotic prescriptions should consider the role that respiratory symptoms and mental health comorbidities may have in driving this practice.
- 1 June 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (6) , 863-871
Incidence and Predictors of Long-Term Hypnotic Receipt among Patients with Chronic Obstructive Pulmonary Disease
Rationale: Many patients with chronic obstructive pulmonary disease (COPD) receive hypnotic prescriptions to mitigate insomnia symptoms. Although clinical practice guidelines advise short-term use, patients often receive these medications on a long-term basis. Because patients with COPD may be more susceptible to adverse effects of hypnotic medication, it is critical that we better understand the incidence and potential influences of this practice. Objectives: To characterize the incidence and predictors of guideline-discordant long-term receipt of hypnotic medications among patients with COPD. Methods: Using nationwide Veterans Health Administration data, we identified patients with clinically diagnosed COPD from 2010 to 2019 without prior hypnotic medication receipt in the previous 1 year. To identify individuals with new hypnotic agent use, we restricted this sample to those who received at least 30 total days of zolpidem, melatonin, trazodone, and/or doxepin within a 90-day period. We defined long-term hypnotic medication receipt as continued availability of one of these hypnotic medications for ≥30 days within the subsequent 90-day period. We then used a mixed-effects logistic regression model to assess patient and site-level associations with long-term receipt. Results: Among 4,262 patients with COPD and new hypnotic medication receipt, 55.6% (n = 2,371) continued to receive hypnotic medications on a long-term basis. Long-term receipt was positively associated with short-acting β-agonist receipt (for every 10% increase in days with short-acting β-agonist availability, odds ratio [OR], 1.03; 95% confidence interval [CI], 1.02–1.05), maintenance inhaler prescriptions (monotherapy, OR, 1.35; 95% CI, 1.10–1.68; dual therapy, OR, 1.43; 95% CI, 1.20–1.70; triple therapy, OR, 1.54; 95% CI, 1.24–1.91), posttraumatic stress disorder (OR, 1.21; 95% CI, 1.02–1.44), major depressive disorder (OR, 1.24; 95% CI, 1.07–1.44), anxiety disorder (OR, 1.21; 95% CI, 1.03–1.44), and more frequent primary care visits (more than five visits in the past 12 mo, OR, 1.86; 95% CI, 1.19–2.90). Long-term receipt was negatively associated with initial receipt of melatonin (OR, 0.70; 95% CI, 0.55–0.91) and more than one pulmonary visit in the previous 12 months (OR, 0.74; 95% CI, 0.56–0.97). Conclusions: Despite guideline recommendations, long-term hypnotic medication receipt is common among patients with COPD. Future work to prevent long-term hypnotic prescriptions should consider the role that respiratory symptoms and mental health comorbidities may have in driving this practice.
- Open Access
- 1 February 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 647-661
Longitudinal Utilization of Invasive Pain Treatment Procedures Among Veterans with Chronic Pain Following Use of Whole Health Services and Complementary and Integrative Health Therapies
Objective: To assess whether Whole Health, a system of care that emphasizes non-pharmacological approaches for chronic pain management, is associated with changes in downstream utilization of invasive pain treatment procedures. Methods: Longitudinal retrospective cohort analysis of VHA administrative data. A total of 53,412 Veterans with chronic pain were identified between April and September 2018, with 584 initiating Whole Health and 3794 initiating a complementary and integrative health (CIH) therapy independent of Whole Health (CIH-only). Whole Health included use of coaching, personal health planning, and other services including CIH referral. CIH therapies included chiropractic care, acupuncture, massage therapy, yoga, Tai Chi/Qigong, and meditation. Propensity score matching was used to estimate expected rates of invasive pain treatment procedures 0– 3, 4– 12, and 13– 18 months after initiating Whole Health or CIH-only compared to similar Veterans who had not engaged in either. Results: Overall, 14% of the population were female, 11% had received prior spine injections, 3.3% had received surgery, and 0.4% had an implantable spinal stimulator. Whole Health use was associated with 42% (− 61% to − 17%) lower utilization of invasive pain procedures at three months compared to matched patients who did not use Whole Health. This reduction was attenuated at 18 months: 22% (− 39% to − 5%). CIH-only was associated with 18% (− 29% to − 4%) lower utilization at three months compared with matched patients, but differences were minimal at 18 months: 1% (− 9% to 9%). Discussion: Whole Health care, including CIH therapies, may help patients interrupt patterns of escalating and invasive pain care.
- 1 February 2025
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 647-661
Open AccessLongitudinal Utilization of Invasive Pain Treatment Procedures Among Veterans with Chronic Pain Following Use of Whole Health Services and Complementary and Integrative Health Therapies
Objective: To assess whether Whole Health, a system of care that emphasizes non-pharmacological approaches for chronic pain management, is associated with changes in downstream utilization of invasive pain treatment procedures. Methods: Longitudinal retrospective cohort analysis of VHA administrative data. A total of 53,412 Veterans with chronic pain were identified between April and September 2018, with 584 initiating Whole Health and 3794 initiating a complementary and integrative health (CIH) therapy independent of Whole Health (CIH-only). Whole Health included use of coaching, personal health planning, and other services including CIH referral. CIH therapies included chiropractic care, acupuncture, massage therapy, yoga, Tai Chi/Qigong, and meditation. Propensity score matching was used to estimate expected rates of invasive pain treatment procedures 0– 3, 4– 12, and 13– 18 months after initiating Whole Health or CIH-only compared to similar Veterans who had not engaged in either. Results: Overall, 14% of the population were female, 11% had received prior spine injections, 3.3% had received surgery, and 0.4% had an implantable spinal stimulator. Whole Health use was associated with 42% (− 61% to − 17%) lower utilization of invasive pain procedures at three months compared to matched patients who did not use Whole Health. This reduction was attenuated at 18 months: 22% (− 39% to − 5%). CIH-only was associated with 18% (− 29% to − 4%) lower utilization at three months compared with matched patients, but differences were minimal at 18 months: 1% (− 9% to 9%). Discussion: Whole Health care, including CIH therapies, may help patients interrupt patterns of escalating and invasive pain care.